Cross-Sector entity

OmniMetrix

Company
5

OmniMetrix is most often covered alongside Acorn Energy, Inc., which appears in 2 of these 2 stories. earnings accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average.

2 verified stories tracked

Last mentioned: Mar 6, 2026

Entity pulse

Recent coverage · OmniMetrix

2 stories
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about OmniMetrix

OmniMetrix is most often covered alongside Acorn Energy, Inc., which appears in 2 of these 2 stories. earnings accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention OmniMetrix, all published on March 6, 2026.

Stories tracked
2
Sources per story
2

Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering OmniMetrix. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Earnings Calls

    Management teams for both companies host conference calls to provide strategic updates and 2026 outlook.

  2. Transcript Release

    Full transcripts of the Q4 2025 earnings calls are made available to the public and analysts.

  3. SEC Filings

    Both ACFN and CRMD file 8-K reports detailing Q4 and full-year 2025 financial results.

Stories mentioning OmniMetrix 2

Finance earnings Neutral 5

Micro-Cap Execution: Acorn Energy and CorMedix Deliver Q4 2025 Results

Acorn Energy and CorMedix both reported Q4 2025 financial results on March 5, 2026, marking a critical transition from development to commercial scaling. While Acorn focuses on high-margin IoT recurring revenue, CorMedix is navigating the complex rollout of its lead product, DefenCath, in the dialysis market.

2 sources
Healthcare market trends Neutral 5

CorMedix and Acorn Energy Report Q4 2025 Growth as Healthcare Tech Scales

CorMedix and Acorn Energy reported strong Q4 2025 results, highlighting a year of significant commercial expansion for specialized healthcare and infrastructure solutions. CorMedix saw accelerated adoption of its antimicrobial catheter lock solution, DefenCath, while Acorn Energy’s OmniMetrix division capitalized on rising demand for remote monitoring in critical healthcare facilities.

2 sources

Source: insidermonkey.com · insidermonkey.com